BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21520112)

  • 1. STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.
    Patel MR; Stadler ME; Deal AM; Kim HS; Shores CG; Zanation AM
    Laryngoscope; 2011 May; 121(5):983-9. PubMed ID: 21520112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.
    Sigstad E; Paus E; Bjøro T; Berner A; Grøholt KK; Jørgensen LH; Sobrinho-Simões M; Holm R; Warren DJ
    Mod Pathol; 2012 Apr; 25(4):537-47. PubMed ID: 22157935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA copy number variations characterize benign and malignant thyroid tumors.
    Liu Y; Cope L; Sun W; Wang Y; Prasad N; Sangenario L; Talbot K; Somervell H; Westra W; Bishop J; Califano J; Zeiger M; Umbricht C
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E558-66. PubMed ID: 23345095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.
    Takano T; Yamada H
    Endocr J; 2009; 56(1):9-16. PubMed ID: 18506086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of suspicious thyroid nodules using four protein biomarkers.
    Cerutti JM; Latini FR; Nakabashi C; Delcelo R; Andrade VP; Amadei MJ; Maciel RM; Hojaij FC; Hollis D; Shoemaker J; Riggins GJ
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3311-8. PubMed ID: 16740752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.
    Ferraz C; Rehfeld C; Krogdahl A; Precht Jensen EM; Bösenberg E; Narz F; Hegedüs L; Paschke R; Eszlinger M
    Thyroid; 2012 Oct; 22(10):1025-30. PubMed ID: 23025542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic Characteristics of Thyroid Nodules Positive for the
    Morariu EM; McCoy KL; Chiosea SI; Nikitski AV; Manroa P; Nikiforova MN; Nikiforov YE
    Thyroid; 2021 Aug; 31(8):1212-1218. PubMed ID: 33487086
    [No Abstract]   [Full Text] [Related]  

  • 10. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules.
    Siddiqui MT; Greene KL; Clark DP; Xydas S; Udelsman R; Smallridge RC; Zeiger MA; Saji M
    Diagn Mol Pathol; 2001 Jun; 10(2):123-9. PubMed ID: 11385322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
    Wong KS; Angell TE; Strickland KC; Alexander EK; Cibas ES; Krane JF; Barletta JA
    Thyroid; 2016 Jul; 26(7):911-5. PubMed ID: 27219469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
    Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
    Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
    Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC
    Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
    Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
    Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
    Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
    Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
    Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular classification of thyroid nodules by cytology.
    Pagedar NA; Chen DH; Wasman JK; Savvides P; Schluchter MD; Wilhelm SM; Lavertu P
    Laryngoscope; 2008 Apr; 118(4):692-6. PubMed ID: 18094649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspiration biopsy-nucleic acid diagnosis for widely used preparative testing].
    Takano T
    Rinsho Byori; 2012 Feb; 60(2):132-8. PubMed ID: 22568094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of genetic biomarkers for distinguishing benign from malignant thyroid neoplasms.
    Nagar S; Ahmed S; Peeples C; Urban N; Boura J; Thibodeau B; Akervall J; Wilson G; Long G; Czako P
    Am J Surg; 2014 Apr; 207(4):596-601. PubMed ID: 24713092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.